BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

246 related articles for article (PubMed ID: 35854180)

  • 21. In-depth characterization of the salivary adenoid cystic carcinoma transcriptome with emphasis on dominant cell type.
    Bell D; Bell AH; Bondaruk J; Hanna EY; Weber RS
    Cancer; 2016 May; 122(10):1513-22. PubMed ID: 26953815
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clinical disease course and survival outcomes following disease recurrence in adenoid cystic carcinoma with and without NOTCH signaling pathway activation.
    Feeney L; Hapuarachi B; Adderley H; Rack S; Morgan D; Walker R; Rauch R; Herz E; Kaye J; Harrington K; Metcalf R
    Oral Oncol; 2022 Oct; 133():106028. PubMed ID: 35952580
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A phase II study of sunitinib in recurrent and/or metastatic adenoid cystic carcinoma (ACC) of the salivary glands: current progress and challenges in evaluating molecularly targeted agents in ACC.
    Chau NG; Hotte SJ; Chen EX; Chin SF; Turner S; Wang L; Siu LL
    Ann Oncol; 2012 Jun; 23(6):1562-70. PubMed ID: 22080184
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Molecular biology of adenoid cystic carcinoma.
    Liu J; Shao C; Tan ML; Mu D; Ferris RL; Ha PK
    Head Neck; 2012 Nov; 34(11):1665-77. PubMed ID: 22006498
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Adenoid cystic carcinoma of salivary and lacrimal gland origin: localization, classification, clinical pathological correlation, treatment results and long-term follow-up control in 84 patients.
    Friedrich RE; Bleckmann V
    Anticancer Res; 2003; 23(2A):931-40. PubMed ID: 12820326
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A phase II study of sorafenib in recurrent and/or metastatic salivary gland carcinomas: Translational analyses and clinical impact.
    Locati LD; Perrone F; Cortelazzi B; Bergamini C; Bossi P; Civelli E; Morosi C; Lo Vullo S; Imbimbo M; Quattrone P; Dagrada GP; Granata R; Resteghini C; Mirabile A; Alfieri S; Orlandi E; Mariani L; Saibene G; Pilotti S; Licitra L
    Eur J Cancer; 2016 Dec; 69():158-165. PubMed ID: 27821319
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Expression of ERBB3 binding protein 1 (EBP1) in salivary adenoid cystic carcinoma and its clinicopathological relevance.
    Sun J; Luo Y; Tian Z; Gu L; Xia SC; Yu Y
    BMC Cancer; 2012 Oct; 12():499. PubMed ID: 23110497
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Differential KIT expression in histological subtypes of adenoid cystic carcinoma (ACC) of the salivary gland.
    Freier K; Flechtenmacher C; Walch A; Devens F; Mühling J; Lichter P; Joos S; Hofele C
    Oral Oncol; 2005 Oct; 41(9):934-9. PubMed ID: 16054424
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pleomorphic adenoma and adenoid cystic carcinoma of salivary glands: E-cadherin immunoexpression and analysis of the CDH1 -160C/A polymorphism.
    Cavalcante RB; Nonaka CF; Rabenhorst SH; da Costa Miguel MC; Pinto LP; de Souza LB
    Arch Oral Biol; 2017 Jan; 73():48-54. PubMed ID: 27665273
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Mutations in the c-Kit gene disrupt mitogen-activated protein kinase signaling during tumor development in adenoid cystic carcinoma of the salivary glands.
    Tetsu O; Phuchareon J; Chou A; Cox DP; Eisele DW; Jordan RC
    Neoplasia; 2010 Sep; 12(9):708-17. PubMed ID: 20824047
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Alterations of Notch pathway in patients with adenoid cystic carcinoma of the trachea and its impact on survival.
    Xie M; Wei S; Wu X; Li X; You Y; He C
    Lung Cancer; 2018 Jul; 121():41-47. PubMed ID: 29858025
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Phase II trial of dasatinib for recurrent or metastatic c-KIT expressing adenoid cystic carcinoma and for nonadenoid cystic malignant salivary tumors.
    Wong SJ; Karrison T; Hayes DN; Kies MS; Cullen KJ; Tanvetyanon T; Argiris A; Takebe N; Lim D; Saba NF; Worden FP; Gilbert J; Lenz HJ; Razak AR; Roberts JD; Vokes EE; Cohen EE
    Ann Oncol; 2016 Feb; 27(2):318-23. PubMed ID: 26598548
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Extracting Potential New Targets for Treatment of Adenoid Cystic Carcinoma using Bioinformatic Methods.
    Forooghi Pordanjani T; Dabirmanesh B; Choopanian P; Mirzaie M; Mohebbi S; Khajeh K
    Iran Biomed J; 2023 Sep; 27(5):294-306. PubMed ID: 37873683
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Association between high expression of phosphorylated Akt and mammalian target of rapamycin and improved survival in salivary gland adenoid cystic carcinoma.
    Ouyang DQ; Liang LZ; Ke ZF; Zheng GS; Weng DS; Yang WF; Su YX; Liao GQ
    Head Neck; 2017 Jun; 39(6):1145-1154. PubMed ID: 28230926
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Systemic therapies for salivary gland adenoid cystic carcinoma.
    Sahara S; Herzog AE; Nör JE
    Am J Cancer Res; 2021; 11(9):4092-4110. PubMed ID: 34659878
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Approaches to the Management of Metastatic Adenoid Cystic Carcinoma.
    Lee RH; Wai KC; Chan JW; Ha PK; Kang H
    Cancers (Basel); 2022 Nov; 14(22):. PubMed ID: 36428790
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Analysis and significance of c-MET expression in adenoid cystic carcinoma of the salivary gland.
    Bell D; Ferrarotto R; Fox MD; Roberts D; Hanna EY; Weber RS; El-Naggar AK
    Cancer Biol Ther; 2015; 16(6):834-8. PubMed ID: 25923130
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Aberrant Wnt-1/beta-catenin signaling and WIF-1 deficiency are important events which promote tumor cell invasion and metastasis in salivary gland adenoid cystic carcinoma.
    Wang R; Geng N; Zhou Y; Zhang D; Li L; Li J; Ji N; Zhou M; Chen Y; Chen Q
    Biomed Mater Eng; 2015; 26 Suppl 1():S2145-53. PubMed ID: 26405993
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Whole exome sequencing of adenoid cystic carcinoma.
    Stephens PJ; Davies HR; Mitani Y; Van Loo P; Shlien A; Tarpey PS; Papaemmanuil E; Cheverton A; Bignell GR; Butler AP; Gamble J; Gamble S; Hardy C; Hinton J; Jia M; Jayakumar A; Jones D; Latimer C; McLaren S; McBride DJ; Menzies A; Mudie L; Maddison M; Raine K; Nik-Zainal S; O'Meara S; Teague JW; Varela I; Wedge DC; Whitmore I; Lippman SM; McDermott U; Stratton MR; Campbell PJ; El-Naggar AK; Futreal PA
    J Clin Invest; 2013 Jul; 123(7):2965-8. PubMed ID: 23778141
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Study of MYB-NFIB chimeric gene expression, tumor angiogenesis, and proliferation in adenoid cystic carcinoma of salivary gland.
    Ono J; Okada Y
    Odontology; 2018 Jul; 106(3):238-244. PubMed ID: 29243184
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.